Sona Nanotech Engages Maxim Group for NASDAQ Listing and Investment Banking Services, and Announces Organizational Change
Halifax, Nova Scotia--(Newsfile Corp. - July 8, 2020) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) ("Sona Nanotech" or the "Company"), a developer of rapid, point-of-care diagnostic tests for COVID-19 and other applications, has engaged Maxim Group, LLC ("Maxim") for general financial advisory and investment banking services in relation to its planned application to list the Company's common shares on the NASDAQ Capital Market ("NASDAQ"). By up-listing to NASDAQ, the Company aspires to...
2020-07-08 6:41 PM EDT
Sona Nanotech Announces Validation Results for its COVID-19 Antigen Test
Halifax, Nova Scotia--(Newsfile Corp. - July 2, 2020) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company"), a developer of rapid, point-of-care diagnostic tests, is pleased to announce that its rapid detection, COVID-19 antigen test's laboratory validation studies of performance levels have resulted in a test sensitivity of 96%, test specificity of 96% and a Limit of Detection ("LOD") of 2.1 x 102 TCID50. Sales of the tests will now be permitted under a 'research use only' label...
2020-07-02 2:52 PM EDT
Sona Nanotech Comments on Trading Activity at Request of IIROC
Halifax, Nova Scotia--(Newsfile Corp. - June 1, 2020) - Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the "Company") has been requested by the Investment Industry Regulatory Organization of Canada (IIROC) to comment on the recent increase in the trading volume and price of the Company's common shares. The Company is not aware of any material change in its business or affairs that has not been publicly disclosed that would account for the recent increase in market activity. As previously...
2020-06-01 9:50 AM EDT
Sona Nanotech Engages MRIGlobal for COVID-19 Test Validation Studies
Halifax, Nova Scotia--(Newsfile Corp. - May 22, 2020) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company") is pleased to announce the engagement of MRIGlobal, a leading applied scientific research organization, to provide analytical and clinical validation studies for Sona's COVID-19 rapid detection, point-of-care, antigen test which will be used for submission to Health Canada for regulatory approval and the FDA for Emergency Use Authorization (EUA). MRIGlobal has three ISO 9001,...
2020-05-22 7:00 AM EDT
Sona Nanotech Provides COVID-19 Antigen Test Progress Update
Halifax, Nova Scotia--(Newsfile Corp. - May 12, 2020) - Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the "Company") is pleased to provide the following update on the development of its rapid-response, COVID-19 antigen test. The Company received confirmation from an independent laboratory that its test achieved a positive response to a recombinant whole spike protein control reagent specific to SARS-CoV2 and matched the limit of detection (LOD) achieved in its own labs. In-house analytical...
2020-05-12 7:28 AM EDT
Sona Nanotech Provides a Progress Update on its Covid-19 Antigen Test
Halifax, Nova Scotia--(Newsfile Corp. - April 13, 2020) - Sona Nanotech Inc. (CSE: SONA) (OTC PINK: SNANF) (the "Company") is pleased to provide an update on the development, manufacturing arrangements and pre-orders for its Covid-19 antigen test. The Company this past week has: Progressed from feasibility and prototype testing to the optimization stage for its Covid-19 antigen rapid response test;Commenced work with two, third-party laboratories to prepare validation protocols; Signed a...
2020-04-13 7:05 AM EDT
Sona Nanotech Awarded $4.1 Million from NGen for Rapid Development and Launch of COVID-19 Antigen Test
Halifax, Nova Scotia--(Newsfile Corp. - March 31, 2020) - Sona Nanotech Inc. (CSE: SONA) (OTC Pink: SNANF) (the "Company") is pleased to announce that it has been awarded a $4.1 million grant from NGen, Canada's Advanced Manufacturing Supercluster, to develop and commercialize its Covid-19 rapid-response antigen test. This non-repayable grant will be used to accelerate the development of a prototype and scale manufacturing capabilities with a view to deploying this Covid-19 virus-detecting,...
2020-03-31 4:32 PM EDT
Sona Nanotech Enters into a Manufacturing Service Agreement and a Sale Letter of Intent Agreement for 2mm Tests
Halifax, Nova Scotia--(Newsfile Corp. - March 30, 2020) - Sona Nanotech Inc. (CSE: SONA), (OTC Pink: SNANF) (the "Company") entered into service and supply agreements with a contract manufacturing organization (CMO) in Europe for the manufacture of its Covid-19 virus-detecting, rapid-response test. The Company also entered into a letter of intent agreement with an international distributor representing the health authority of a G20 country for the purchase of 2,000,000 test kits. The Company...
2020-03-30 1:00 PM EDT
Sona Nanotech Obtains New OTC Trading Symbol
Halifax, Nova Scotia--(Newsfile Corp. - March 20, 2020) - Sona Nanotech Inc. (CSE: SONA) (OTC Pink: SNANF) (the "Company") is pleased to announce that it has undertaken to further develop the U.S. trading market for its common shares. As a first step, Sona recently applied for a new OTC trading symbol that will more accurately reflect the company's current name and business. At the market open today, the symbol was changed from "LMTCF" to "SNANF". Investors, brokers and other market...
2020-03-20 8:10 AM EDT
RETRANSMISSION: Sona Achieves Significant Milestone in Covid-19 Test Development
Halifax, Nova Scotia--(Newsfile Corp. - March 19, 2020) - Sona Nanotech Inc. (CSE: SONA) (OTC PINK: LMTCF) ("Sona") is pleased to provide an update on the development of its rapid-response Covid-19 test. Sona is leading a consortium of diagnostic test developers including GE Healthcare Life Sciences, to create a rapid-response, lateral flow test that will directly identify the Covid-19 virus and provide in-field test results in minutes, without the use of specialized laboratory equipment or...
2020-03-19 7:30 AM EDT
Sona Achieves Significant Milestone in Covid-19 Test Development
Halifax, Nova Scotia--(Newsfile Corp. - March 18, 2020) - Sona Nanotech Inc. (CSE: SONA) (OTC Pink: LMTCF) ("Sona") is pleased to provide an update on the development of its rapid-response Covid-19 test. Sona is leading a consortium of diagnostic test developers including GE Healthcare Life Sciences, to create a rapid-response, lateral flow test that will directly identify the Covid-19 virus and provide in-field test results in minutes, without the use of specialized laboratory equipment or...
2020-03-18 6:06 PM EDT
Sona Nanotech Grants Options
Halifax, Nova Scotia--(Newsfile Corp. - March 17, 2020) - Sona Nanotech Inc. (CSE: SONA) (the "Company") is pleased to announce that it has granted 1,100,000 incentive stock options under the Company's Stock Option Plan ("Option Plan") of which 550,000 have been granted to Directors and Officers. Each option is exercisable into one common share at a price of $0.60 per share and will vest at the rate of 25% every six months. The options will expire five years from...
2020-03-17 8:44 AM EDT
Sona Provides Corporate Update
Halifax, Nova Scotia--(Newsfile Corp. - March 12, 2020) - Sona Nanotech Inc. (CSE: SONA) (OTC Pink: LMTCF) ("Sona") is pleased to provide a corporate update on recent activities. In the past several weeks, Sona has been focused on work related to the development of a rapid response COVID-19 lateral flow test. This update will outline progress and advancements on Sona's COVID-19 test and other corporate developments.The Sona Advantage Sona is a research and development company that owns...
2020-03-12 7:30 AM EDT
Sona Provides Update on Coronavirus Rapid Screening Test and Announces Scientific Advisors
Halifax, Nova Scotia--(Newsfile Corp. - March 6, 2020) - Sona Nanotech Inc. (CSE: SONA) (OTC: LMTCF) ("Sona") is pleased to provide an update on its Covid-19 rapid screening test as well as announcing the addition of Fiona Marshall and Sandy Morrison as scientific advisors for the Covid-19 test development.Fiona Marshall will assist the Sona team with scientific considerations of test development, manufacturing set-up, quality control and regulatory approval. Ms. Marshall is the current CEO...
2020-03-06 7:52 AM EST
Sona Partners With GE Healthcare Life Sciences to Complete Coronavirus Rapid Screening Test
Halifax, Nova Scotia--(Newsfile Corp. - March 4, 2020) - Sona Nanotech Inc. (CSE: SONA) (OTC PINK: LMTCF) ("Sona") and GE Healthcare Life Sciences will jointly complete test development of the Sona Covid-19 Coronavirus rapid response lateral flow test, and will use GE Healthcare Life Sciences' Fast Flow High Performance Membrane (FFHP) in production of the test. Sona will retain all commercial rights to the resulting test.The companies will work in parallel to complete the test prior to field...
2020-03-04 7:00 AM EST
Sona Partners with GE Healthcare Life Sciences to Complete Coronavirus Rapid Screening Test
Halifax, Nova Scotia--(Newsfile Corp. - March 3, 2020) - Sona Nanotech Inc. (CSE: SONA) ("Sona") and GE Healthcare Life Sciences will jointly complete test development of the Sona Covid-19 Coronavirus rapid response lateral flow test, and will use GE Healthcare Life Sciences' Fast Flow High Performance Membrane (FFHP) in production of the test. Sona will retain all commercial rights to the resulting test.The companies will work in parallel to complete the test prior to field testing. GE...
2020-03-03 2:56 PM EST
Sona Announces Data Partnership for Covid-19 Rapid Screening Test
Halifax, Nova Scotia--(Newsfile Corp. - February 18, 2020) - Sona Nanotech Inc. (CSE: SONA) has announced a partnership with UK-based medical technology company Bond Digital Health (Bond) to add data capture and analysis to its coronavirus (Covid-19) rapid screening test currently in development.This data partnership will allow test result data to be collected through either a reader system or mobile app before being securely stored in the cloud. The data can be accessed and analysed on an...
2020-02-18 7:30 AM EST
Sona announces key partner for Coronavirus Rapid Screening Test
Halifax, Nova Scotia--(Newsfile Corp. - February 13, 2020) - Sona Nanotech Inc. (CSE: SONA) ("Sona") has secured an agreement with The Native Antigen Company ("Native") to supply biologics for the recently announced Covid-19 Coronavirus rapid screening test, currently in development by Sona (See Sona news release dated February 10, 2020).Native is a leading supplier of native and recombinant antigens for emerging and endemic infectious diseases. Native is one of the first recognised suppliers...
2020-02-13 8:00 AM EST
Sona Develops Rapid Screening Test for Coronavirus
Halifax, Nova Scotia--(Newsfile Corp. - February 10, 2020) - Sona Nanotech Inc. ("Sona") (CSE: SONA) is deploying its proprietary nanotechnology in the development of a rapid screening test for the current Coronavirus, "nCoV19". Sona is developing a quick-response lateral flow test to screen patients for the nCoV19 virus. When completed, the test is expected to produce results in 5-15 minutes and is anticipated to cost less than $50. There is currently no lateral flow test specific to the...
2020-02-10 7:30 AM EST
Sona Announces Conversion of Notes Payable
Halifax, Nova Scotia--(Newsfile Corp. - January 14, 2020) - Sona Nanotech Inc. (CSE: SONA) ("Sona" or the "Company"): The Company is converting notes payable of $95,000 and accrued interest of $67,322 owed to certain non-arm's length note holders and notes payable of $200,000 and accrued interest of $141,732 owed to certain arm's length note holders. The notes payable will be settled in full by the issuance to these note holders of an aggregate of 2,520,270 common shares...
2020-01-14 6:00 AM EST